Clinical Trial 45963

Long Beach, CA 90806


The primary purpose of this study is to evaluate the safety and tolerability of SAGE-718 and its effects on cognitive, neuropsychiatric, and motor symptoms in participants with PD-MCI.

  • Meet the following criteria for PD-MCI: Have a confirmed diagnosis of idiopathic PD according to 2015 Movement Disorder Society (MDS) clinical diagnostic criteria; Meet MDS Task Force Criteria for MCI in PD.
  • Have a score of 20 to 25 (inclusive) on the Montreal Cognitive Assessment (MoCA) at Screening.
  • Meet criteria for Hoehn & Yahr Stage I to III (mild to moderate motor severity) at Screening.
  • Have stable motor symptoms for at least 4 weeks prior to screening, in the opinion of the investigator.

Qualified Participants May Receive:

Compensation for participating up to $900.00 over the study length (28 days)

Available At:

Collaborative Neuroscience Research, LLC

Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.